Does Razadyne ER (galantamine) cause side effects?
Razadyne ER (galantamine) is a cholinesterase inhibitor used to treat patients with Alzheimer's disease, a form of dementia. Cholinesterase inhibitors inhibit (block) the action of acetylcholinesterase, the enzyme responsible for the destruction of acetylcholine. Acetylcholine is one of several neurotransmitters in the brain, chemicals that nerve cells use to communicate with one another.
Reduced levels of acetylcholine in the brain are believed to be responsible for some of the symptoms of Alzheimer's disease. By blocking the enzyme that destroys acetylcholine, Razadyne ER increases the concentration of acetylcholine in the brain, and this increase is believed to be responsible for the improvement in thinking.
Common side effects of Razadyne ER are usually mild and temporary and include
These side effects generally occur during the beginning of treatment or when the dose is increased.
Other important side effects of Razadyne ER include
- headache,
- abdominal pain,
- fatigue,
- slow heart rate,
- depression,
- sleepiness, and
- fainting.
Drug interactions of Razadyne ER include drugs with anticholinergic properties and which cross into the brain, such as atropine, benztropine and trihexyphenidyl, which produce opposite effects to (counteract) Razadyne ER.
Drugs such as ketoconazole and paroxetine that reduce the activity of liver enzymes that break down Razadyne ER may increase blood levels of and, therefore, the side effects of Razadyne ER.
Razadyne ER may add to the neuromuscular blocking effect of succinylcholine and similar drugs that are used during surgical anesthesia.
Unlike donepezil, Razadyne ER does not increase blood levels of other medications and increase their risk for side effects.
No studies have been performed with use of Razadyne ER in pregnant women. Physicians must weigh the potential benefits against the potential risks of Razadyne ER before prescribing it for pregnant women.
It is unknown if Razadyne ER is secreted in breast milk. Consult your doctor before breastfeeding.
What are the important side effects of Razadyne ER (galantamine)?
The most frequent side effects seen with galantamine are:
- nausea,
- vomiting,
- diarrhea, and
- anorexia (weight loss).
These side effects generally occur during the beginning of treatment or when the dose is increased. These side effects typically are mild and temporary. Taking galantamine with food and ensuring adequate fluid intake may reduce the impact of these side effects.
Other important side effects include:
- headache,
- abdominal pain,
- fatigue,
- slow heart rate,
- depression,
- sleepiness, and
- fainting.
Razadyne ER (galantamine) side effects list for healthcare professionals
Serious adverse reactions are discussed in more detail in the following sections of the labeling:
- Serious skin reactions
- Cardiovascular Conditions
- Gastrointestinal Conditions
- Genitourinary Conditions
- Neurological Conditions
- Pulmonary Conditions
- Deaths in subjects with mild cognitive impairment (MCI)
Clinical Trials Experience
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.
The most common adverse reactions in galantamine-treated patients from double-blind clinical trials (≥5%) were
- nausea,
- vomiting,
- diarrhea,
- dizziness,
- headache, and
- decreased appetite.
The most common adverse reactions associated with discontinuation (≥1%) in galantamine-treated patients from double-blind clinical trials were
- nausea (6.2%),
- vomiting (3.3%),
- decreased appetite (1.5%), and
- dizziness (1.3%).
The safety of the extended-release capsule and immediate-release tablet formulations of galantamine was evaluated in 3956 galantamine-treated patients who participated in 8 placebo-controlled clinical studies and 1454 subjects in 5 open-label clinical studies with mild to moderate dementia of the Alzheimer’s type.
In clinical studies, the safety profile of once-daily treatment with extended-release galantamine was similar in frequency and nature to that seen with tablets. The information presented in this section was derived from pooled double-blind studies and from pooled open-label data.
Commonly-Observed Adverse Reactions In Double-Blind, Placebo-Controlled Clinical Trials
Table 1 lists the adverse reactions reported in ≥1% of galantamine-treated patients in 8 placebo-controlled, double-blind clinical trials.
Table 1. Adverse Reactions Reported by ≥1% of Galantamine-Treated Patients in Pooled Placebo-Controlled, Double-Blind Clinical Trials
System/Organ Class Adverse Reaction | Galantamine (n=3956) % | Placebo (n=2546) % |
Metabolism and Nutrition Disorders | ||
Decreased appetite | 7.4 | 2.1 |
Psychiatric Disorders | ||
Depression | 3.6 | 2.3 |
Nervous System Disorders | ||
Headache | 7.1 | 5.5 |
Dizziness | 7.5 | 3.4 |
Tremor | 1.6 | 0.7 |
Somnolence | 1.5 | 0.8 |
vSyncope | 1.4 | 0.6 |
Lethargy | 1.3 | 0.4 |
Cardiac Disorders | ||
Bradycardia | 1.0 | 0.3 |
Gastrointestinal Disorders | ||
Nausea | 20.7 | 5.5 |
Vomiting | 10.5 | 2.3 |
Diarrhea | 7.4 | 4.9 |
Abdominal discomfort | 2.1 | 0.7 |
Abdominal pain | 3.8 | 2.0 |
Dyspepsia | 1.5 | 1.0 |
Musculoskeletal and Connective Tissue Disorders | ||
Muscle spasms | 1.2 | 0.5 |
General Disorders and Administration Site Conditions | ||
Fatigue | 3.5 | 1.8 |
Asthenia | 2.0 | 1.5 |
Malaise | 1.1 | 0.5 |
Investigations | ||
Decreased weight | 4.7 | 1.5 |
Injury, Poisoning and Procedural Complications | ||
Fall | 3.9 | 3.0 |
Laceration | 1.1 | 0.5 |
The majority of these adverse reactions occurred during the dose-escalation period. In those patients who experienced the most frequent adverse reaction, nausea, the median duration of the nausea was 5-7 days.
Other Adverse Reactions Observed In Clinical Trials Of Galantamine
The following adverse reactions occurred in <1% of all galantamine-treated patients (N=3956) in the above double-blind, placebo-controlled clinical trial data sets. In addition, the following also includes all adverse reactions reported at any frequency rate in patients (N=1454) who participated in open-label studies. Adverse reactions listed in Table 1 above were not included below:
- Metabolism and Nutrition Disorders: Dehydration
- Nervous System Disorders: Dysgeusia, Hypersomnia, Paresthesia
- Eye Disorders: Blurred vision
- Cardiac Disorders: First degree atrioventricular block, Palpitations, Sinus bradycardia, Supraventricular extrasystoles
- Vascular Disorders: Flushing, Hypotension
- Gastrointestinal Disorders: Retching
- Skin and Subcutaneous Tissue Disorders: Hyperhidrosis
- Musculoskeletal and Connective Tissue Disorders: Muscular weakness
Discontinuations Due To Adverse Reactions
In the 8 placebo-controlled studies of adults, 418 (10.6%) galantamine-treated patients (N=3956) and 56 (2.2%) placebo patients (N=2546) discontinued due to an adverse reaction. Those events with an incidence of ≥0.5% in the galantamine-treated patients included
- nausea (245, 6.2%),
- vomiting (129, 3.3%),
- decreased appetite (60, 1.5%),
- dizziness (50, 1.3%),
- diarrhea (31, 0.8%),
- headache (29, 0.7%), and
- decreased weight (26, 0.7%).
The only event with an incidence of ≥0.5% in placebo patients was nausea (17, 0.7%).
In the 5 open-label studies, 103 (7.1%) patients (N=1454) discontinued due to an adverse reaction. Those events with an incidence of ≥0.5% included
- nausea (43, 3.0%),
- vomiting (23, 1.6%),
- decreased appetite (13, 0.9%),
- headache (12, 0.8%),
- decreased weight (9, 0.6%),
- dizziness (8, 0.6%), and
- diarrhea (7, 0.5%).
Postmarketing Experience
The following additional adverse reactions have been identified during post-approval use of Razadyne ER and Razadyne. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency:
- Immune System Disorders: Hypersensitivity
- Psychiatric Disorders: Hallucinations
- Nervous System Disorders: Seizures
- Ear and Labyrinth Disorders: Tinnitus
- Cardiac Disorders: Complete atrioventricular block
- Vascular Disorders: Hypertension
- Hepatobiliary Disorders: Hepatitis, Increased hepatic enzyme
- Skin and Subcutaneous Tissue Disorders: Stevens-Johnson syndrome, Acute generalized exanthematous pustulosis, Erythema multiforme
What drugs interact with Razadyne ER (galantamine)?
Use With Anticholinergics
- Galantamine has the potential to interfere with the activity of anticholinergic medications.
Use With Cholinomimetics And Other Cholinesterase Inhibitors
- A synergistic effect is expected when cholinesterase inhibitors are given concurrently with succinylcholine, other cholinesterase inhibitors, similar neuromuscular blocking agents or cholinergic agonists such as bethanechol.
Summary
Razadyne ER (galantamine) is a cholinesterase inhibitor used to treat patients with Alzheimer's disease, a form of dementia. Razadyne ER increases the concentration of acetylcholine in the brain, and this increase is believed to be responsible for the improvement in thinking. Common side effects of Razadyne ER are usually mild and temporary and include nausea, vomiting, diarrhea, and weight loss. These side effects generally occur during the beginning of treatment or when the dose is increased. No studies have been performed with the use of Razadyne ER in pregnant women. It is unknown if Razadyne ER is secreted in breast milk.
Multimedia: Slideshows, Images & Quizzes
-
The Stages of Dementia: Alzheimer's Disease and Aging Brains
What are the symptoms of dementia? What causes dementia? Dementia includes many disorders, such as Lewy Body dementia,...
-
Healthy Aging: Reasons for Memory Loss and Dementia Risk
Forget your keys? That might be absentmindedness. Forget what you did this morning? That might be a more serious memory problem....
-
Brain Health: Foods that May Lower Dementia Risk
What foods are associated with Alzheimer's disease and other forms of dementia? Cognitive function is predicated on good...
-
Alzheimers Disease Quiz: Stages, Symptoms & Signs
Take the Alzheimer's Quiz to discover some of the mysteries behind this cognitive disorder. Learn causes, symptoms, treatments,...
-
Picture of Vascular (Multi-Infarct) Dementia 2
There are several types of vascular dementia, which vary slightly in their causes and symptoms. See a picture of Vascular...
-
Picture of Lewy Body Dementia
Lewy body dementia (LBD) is one of the most common types of progressive dementia. See a picture of Lewy Body Dementia (LBD) and...
-
Picture of Frontotemporal Dementia (FTD)
Frontotemporal dementia, sometimes called frontal lobe dementia, describes a group of diseases characterized by degeneration of...
-
Picture of HIV-associated Dementia (HAD)
A 40-year-old woman diagnosed with HIV presented with confusion and decline in memory. See a picture of HIV-associated Dementia...
-
Picture of Alzheimer's Disease
In the early stages of Alzheimer's disease, patients may experience memory impairment, lapses of judgment, and subtle changes in...
-
Picture of Vascular (Multi-Infarct) Dementia 1
Vascular dementia is the second most common cause of dementia, after Alzheimer's disease. See a picture of Vascular...
-
Dementia and Alzheimer's: 13 Bad Brain Health Habits
Good brain health depends on exercising regularly, eating well, and getting enough sleep. Learn how to develop good health habits...
-
Alzheimer's Disease Symptoms & Early Diagnosis
Memory loss and confusion can be signs of normal aging, but also warning signs of Alzheimer's disease. The early stages of...
-
Dementia and Alzheimer's: Is It Aging or Alzheimer's?
Learn the difference between memory problems that can happen to all of us as we get older and real warning signs of dementia.
-
Caring for Someone With Alzheimer's Disease
Learn to spot early signs and symptoms of Alzheimer's disease and find out what to expect from the different stages of...
-
Alzheimer's Diagnosis: Your Family's Questions Answered
What is Alzheimer's diagnosis criteria and how do you tell the difference between Alzheimer’s disease and dementia? Find out the...
Related Disease Conditions
-
Dementia
Dementia is defined as a significant loss of intellectual abilities such as memory capacity, severe enough to interfere with social or occupational functioning. There are several different types of dementia, including cortical, subcortical, progressive, primary, and secondary dementias. Other conditions and medication reactions can also cause dementia. Dementia is diagnosed based on a certain set of criteria. Treatment for dementia is generally focused on the symptoms of the disease.
-
What Are the Seven Stages of Lewy Body Dementia?
Lewy body dementia (LBD) or dementia with Lewy bodies (DLB) is associated with protein deposits in the brain that cause disruptions in the normal functioning of the brain. Diagnosing the disease is extremely tough because its symptoms may resemble other brain diseases. There are seven stages of Lewy body dementia.
-
Alzheimer's Disease
Alzheimer's disease is a common cause of dementia. Symptoms and warning signs of Alzheimer's disease include memory loss, difficulty performing familiar tasks, disorientation to time and place, misplacing things, and more. The biggest risk factor for Alzheimer's disease is increased age. Treatment for Alzheimer's is often targeted toward decreasing the symptoms and progression of the disease.
-
What Are the Seven Stages of Dementia?
The progression of dementia (in Alzheimer’s disease) has been divided into seven stages. Learn about treatment, prevention, and foods that can help fight dementia.
-
Early Warning Signs and Stages of Dementia
Dementia is a decline and or loss of behavior of mental abilities, loss of judgment, language, and reasoning. Early warning signs of dementia include misplacing items, difficulty planning or problem solving, poor work performance, difficulty doing familiar tasks, and withdrawal from social activities. There are seven stages of dementia that range from stage 1, with no cognitive decline to stage 7, which is severe dementia.
-
What Is the Difference Between Dementia and Alzheimer's?
Dementia is a group of symptoms (syndrome) characterized by a decline in memory, thinking and reasoning. Although dementia is a cluster of symptoms, Alzheimer’s is a slowly progressive disorder of the brain that destroys memory and thinking skills.
-
7 Alzheimer's Disease Stages and Symptoms
The signs and symptoms of Alzheimer's disease depend on the stage of the disease. Some doctors and researchers disagree in regard to the number of stages of Alzheimer's disease (from 1 to 7 stages). The Global Deterioration Scale or GDS identifies seven stages of Alzheimer's disease that include stage 1 (no impairment), stage 2 (very mild cognitive decline), stage 3 (mild cognitive decline), stage 4 (moderate cognitive decline), stage 5 (moderately severe decline), stage 6 (severe decline), and stage 7 (very severe decline). There is no cure for Alzheimer's disease, however, there are drugs and therapies to help the symptoms Alzheimer's disease causes.
-
What Are the Seven Stages of Alzheimer's?
While not everyone will experience the same symptoms, and the disease may progress at a different rate for each individual, the typical progression of Alzheimer’s disease can be broken down into seven stages.
-
Alzheimer's Disease: Financial Planning
Alzheimer's disease can be not only mentally devastating to an indivdiual and family, it can also be emotionally devastating. Preparing financially for someone with Alzheimer's disease is an important task to complete so that bills get paid and the best coverage is provided. Learn what Medicade and Medicare will provide for a patient.
Treatment & Diagnosis
- Alzheimers Disease FAQs
- Alzheimer's Disease - NSAID Protection?
- Alzheimer's Disease: Drug for Symptoms
- Dementia Prevention: Brain Exercise
- Caring for Someone with Alzheimer's
- Robin Williams and Lewy Body Dementia
- Lewy Body Dementia (LBD) Symptoms and Prognosis
- Gum Disease Linked to Alzheimer's Disease
Medications & Supplements

Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Professional side effects and drug interactions sections courtesy of the U.S. Food and Drug Administration.